NEW YORK ( TheStreet) -- Cyberonics (Nasdaq: CYBX) hit a new 52-week high Monday as it is currently trading at $39.28, above its previous 52-week high of $39.18 with 16,731 shares traded as of 9:53 a.m. ET. Average volume has been 196,400 shares over the past 30 days. Cyberonics has a market cap of $901.5 million and is part of the health care sector and health services industry. Shares are up 16.1% year to date as of the close of trading on Friday. Cyberonics, Inc., a neuromodulation company, engages in the design, development, sale, and marketing of implantable medical devices that provide vagus nerve stimulation (VNS) therapy for the treatment of refractory epilepsy and treatment-resistant depression. The company has a P/E ratio of 33.6, above the average health services industry P/E ratio of 30.5 and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter